Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Total Valuation

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. carries a market capitalization of 22.80B, placing it among publicly traded companies globally. Its enterprise value stands at 45.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. currently has 919.06M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 45.04, and the price-to-book ratio stands at 46.50.

Enterprise Valuation

Financial Position

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. maintains a current ratio of 0.79, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 161.89, indicating elevated leverage, while an interest coverage ratio of -1.04 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has paid 8.68M in income taxes, reflecting an effective tax rate of 57.36.

Stock Price Statistics

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s stock has declined approximately -46.61072% over the past 52 weeks. The 50-day moving average sits at 36.51, while the 200-day moving average is 47.86.

Income Statement

Over the trailing twelve months, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. generated 954.64M in revenue and converted that into -231.66M in net income, yielding earnings per share of -0.27. EBITDA reached -109.63M, while operating income came in at -109.63M.

Balance Sheet

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. holds 217.80M in cash and equivalents against 2.43B in total debt, resulting in a net debt position of 1.34B. Total book value stands at 924.85M, with working capital of -522.87M providing operational flexibility.

Cash Flow

After subtracting -193.62M in capital expenditures, free cash flow totaled -193.62M - equivalent to -0.21 per share.

Margins

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates with a gross margin of 15.45, reflecting its pricing power and cost economics. The operating margin of -11.48 and net profit margin of -24.27 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -44.90 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s most recent stock split took place on April 20, 2016 with a 5:9 split ratio.

Scores

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. posts an Altman Z-Score of 8.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.